Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference30 articles.
1. (FDA). FaDA (2019) Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products guidance for industry [Internet]. Silver Spring, MD: FDA. https://www.fda.gov/media/121320/download
2. Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Solomon SD (2014) Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail 7(4):590–595. https://doi.org/10.1161/circheartfailure.113.001281
3. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116(13):1482–1487. https://doi.org/10.1161/circulationaha.107.696906
4. Ibrahim NE, Burnett JC Jr, Butler J, Camacho A, Felker GM, Fiuzat M, O’Connor C, Solomon SD, Vaduganathan M, Zile MR, Januzzi JL Jr (2020) Natriuretic peptides as inclusion criteria in clinical trials: a JACC heart failure position paper. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2019.12.010
5. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA (2004) Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial. Circulation 110(13):1780–1786. https://doi.org/10.1161/01.Cir.0000143059.68996.A7
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献